BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38057203)

  • 61. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
    Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
    Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy.
    Schlafstein A; Liu Y; Goyal S; Kahn S; Godette K; Lin J; Torres MA; Royce TJ; Patel SA
    Clin Breast Cancer; 2022 Feb; 22(2):127-135. PubMed ID: 34229943
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery.
    Sackey H; Johansson H; Sandelin K; Liljegren G; MacLean G; Frisell J; Brandberg Y
    Eur J Surg Oncol; 2015 Apr; 41(4):577-84. PubMed ID: 25659877
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast Cancer.
    Bitencourt A; Rossi Saccarelli C; Morris EA; Flynn J; Zhang Z; Khan A; Gillespie E; Cahlon O; Mueller B; Cuaron JJ; McCormick B; Powell SN; Plitas G; Razavi P; Pinker K; Riedl CC; Sutton EJ; Braunstein LZ
    JAMA Netw Open; 2020 Oct; 3(10):e2018790. PubMed ID: 33034638
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes.
    Yang Z; Lan X; Huang Z; Yang Y; Tang Y; Jing H; Wang J; Zhang J; Wang X; Gao J; Wang J; Xuan L; Fang Y; Ying J; Li Y; Huang X; Wang S
    Breast; 2020 Oct; 53():143-151. PubMed ID: 32823167
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy.
    Moossdorff M; Nakhlis F; Hu J; Barry WT; Losk K; Haskett C; Smidt ML; King TA
    Ann Surg Oncol; 2018 Sep; 25(9):2612-2619. PubMed ID: 29855827
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
    Fan YJ; Li JC; Zhu DM; Zhu HL; Zhao Y; Zhu XB; Wu G; Bai TT
    BMC Surg; 2023 Jul; 23(1):209. PubMed ID: 37495945
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety and Accuracy of Sentinel Lymph Node Biopsy Alone in Clinically Node-Positive Patients Undergoing Upfront Surgery for Invasive Breast Cancer: A Systematic Review.
    Lovrics O; Tao B; Parvez E
    Curr Oncol; 2023 Mar; 30(3):3102-3110. PubMed ID: 36975448
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regional Nodal Management in the Setting of Up-Front Surgery.
    Braunstein LZ; Morrow M
    Semin Radiat Oncol; 2022 Jul; 32(3):221-227. PubMed ID: 35688520
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictors of positive axillary non-sentinel lymph nodes in breast cancer patients with positive sentinel lymph node biopsy after neoadjuvant systemic therapy.
    Leonardi MC; Arrobbio C; Gandini S; Volpe S; Colombo F; La Rocca E; Galimberti V; Kahler-Ribeiro-Fontana S; Fodor C; Dicuonzo S; Rojas DP; Zerella MA; Morra A; Montagna E; Colleoni M; Mazzarol G; Travaini LL; Zaffaroni M; Veronesi P; Orecchia R; Jereczek-Fossa BA
    Radiother Oncol; 2021 Oct; 163():128-135. PubMed ID: 34461184
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Axillary treatment in breast cancer: surgery, radiotherapy, or none of these?].
    Boersma L; van der Sangen MJ
    Ned Tijdschr Geneeskd; 2015; 159():A9510. PubMed ID: 26488194
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
    Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
    Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hypofractionated regional nodal irradiation for breast cancer: examining the data and potential for future studies.
    Badiyan SN; Shah C; Arthur D; Khan AJ; Freedman G; Poppe MM; Vicini FA
    Radiother Oncol; 2014 Jan; 110(1):39-44. PubMed ID: 24440047
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
    Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
    BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
    [TBL] [Abstract][Full Text] [Related]  

  • 77. De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy.
    Liu J; Huang S; Bi Z; Zhang X; He Z; Lan X; Tan Y; Lin X; Zhou W; Huang X
    Front Oncol; 2023; 13():1280900. PubMed ID: 38023183
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
    Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C
    Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Positive axillary sentinel lymph node: is axillary dissection always necessary?
    Galimberti V; Chifu C; Rodriguez Perez S; Veronesi P; Intra M; Botteri E; Mastropasqua M; Colleoni M; Luini A; Veronesi U
    Breast; 2011 Oct; 20 Suppl 3():S96-8. PubMed ID: 22015302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.